University of California San Francisco

Biography

Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2019
University of California, San Francisco Transplant Fellowship School of Medicine 1995
University of California, San Francisco Post-Doc Fellow/Scholar School of Medicine 1991
University of Minnesota M.D. School of Medicine 1986

Board Certifications

  • American Board of Surgery, 1995

Clinical Expertise

Bile Duct Injuries
Bile Duct Strictures
Cholangiocarcinoma (Bile Duct Cancer)
Choledochal Cyst Disease
Dialysis Access
Expanded Criteria Donor Kidney Transplantation
Fulminant Hepatic Failure
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Intestinal Transplantation and Rehabilitation
Kidney and LIver Transplantation in HIV Patients
Kidney Auto-transplantation
Kidney Transplantation
Laparoscopic Donor Nephrectomy
Laparoscopic Kidney and Liver Surgery
Liver Transplantation
Living Donor Kidney Transplantation
Living Donor Liver Transplantation
Pancreas Transplantation
Pediatric Kidney Transplantation
Pediatric Liver Transplantation
Polycystic Kidney Disease
Polycystic Liver Disease
Portal Hypertension
Surgical Shunts

Grants and Funding

  • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients | NIH | 2002-09-01 - 2015-08-31 | Role: Principal Investigator

Research Narrative

Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

Research Interests

Delivery of Immunosuppressive Agents to Organ Allografts

Ischemia Reperfusion Injury

Improvement Organ Function in Deceased Donors

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 125
  1. Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability.
    Tran G, Ramaswamy K, Chi T, Meng M, Freise C, Stoller ML| | PubMed
  2. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.
    Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE| | PubMed
  3. Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).
    Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS, Merion RM, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Burton JR, Shaked A, Butt Z| | PubMed
  4. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
    Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA| | PubMed
  5. Emesis following laparoscopic left donor nephrectomy.
    Luu HY, Ulloa JG, Roll GR, Freise CE| | PubMed
  6. Ex vivo split-liver transplantation: the true right/left split.
    Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| | PubMed
  7. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, A2ALL Study Group| | PubMed
  8. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma.
    Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA| | PubMed
  9. Complications of living donor hepatic lobectomy--a comprehensive report.
    Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM, A2ALL Study Group| | PubMed
  10. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP| | PubMed
125
View all 125 Publications